Layer‐by‐layer nanoparticles for novel delivery of cisplatin and PARP inhibitors for platinum‐based drug resistance therapy in ovarian cancer

Advanced staged high‐grade serous ovarian cancer (HGSOC) is the leading cause of gynecological cancer death in the developed world, with 5‐year survival rates of only 25–30% due to late‐stage diagnosis and the shortcomings of platinum‐based therapies. A Phase I clinical trial of a combination of fre...

Descripción completa

Detalles Bibliográficos
Autores principales: Mensah, Lawrence B., Morton, Stephen W., Li, Jiahe, Xiao, Haihua, Quadir, Mohiuddin A., Elias, Kevin M., Penn, Emily, Richson, Aysen K., Ghoroghchian, Paiman Peter, Liu, Joyce, Hammond, Paula T.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2019
Materias:
Research Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6584097/
https://www.ncbi.nlm.nih.gov/pubmed/31249881
http://dx.doi.org/10.1002/btm2.10131

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6584097/
https://www.ncbi.nlm.nih.gov/pubmed/31249881
http://dx.doi.org/10.1002/btm2.10131

Ejemplares similares